Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Brief summary (registry, in English)

Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.

What you commit to

• Study type: Observational
• Participants enrolled: 827
• From 5 Feb 2018 to the primary completion date, 11 Sept 2024
• 62 sites in 16 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (62)

Sites in registry order. Pick your city on the disease page to sort them by distance.